Financials
- Market Capitalization 334.89 M
- Employee 22
- Founded 2017
- CEO N/A
- Website www.q32bio.com
- Headquarter Delaware, United States
- FIGI BBG00CTTJWQ9
- Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.37
ratio cours/chiffre d'affaires
0.76
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3021 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.88 USD | +1.21% | -6.26% | -10.94% | +24.06% | 437.84 M USD | ||
| 3106 | UPB Upstream Bio, Inc. - Common Stock | 7.25 USD | -0.41% | -7.76% | +17.12% | -38.56% | 394.54 M USD | ||
| 3329 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.59 USD | -0.75% | -5.69% | -4.64% | -6.23% | 305.94 M USD | ||
| 3738 | OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 4.21 USD | +2.43% | -3.22% | +2.18% | +71.84% | 170.06 M USD |